Cohance Lifesciences Ltd

COHANCE NSE Healthcare Pharmaceuticals
Nifty 500 Smallcap 50 Smallcap 100 Smallcap 250
₹440.20
-1.15%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Cohance Lifesciences Ltd belong to?
Cohance Lifesciences Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of COHANCE?
As of the latest available quote, COHANCE traded at ₹440.20. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of COHANCE?
Cohance Lifesciences Ltd has a price-to-earnings (P/E) ratio of about 158.92. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of COHANCE?
The market capitalisation of Cohance Lifesciences Ltd is approximately ₹16,842 Cr.
Is Cohance Lifesciences Ltd profitable?
For its latest reported financial year, Cohance Lifesciences Ltd recorded a net profit margin of about 6.61%.
Does COHANCE pay a dividend?
Cohance Lifesciences Ltd does not currently show a dividend yield in our data.
What is the return on equity (ROE) of COHANCE?
Cohance Lifesciences Ltd has a return on equity (ROE) of about 4.89%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of COHANCE?
Over the past 52 weeks, COHANCE has traded between a low of ₹266.70 and a high of ₹996.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.